Michael B. Atkins's most recent trade in Werewolf Therapeutics Inc was a trade of 27,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics Inc | Michael B. Atkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Michael B. Atkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 6,723 | 6,723 | - | - | Stock Option (right to buy) | |
| Werewolf Therapeutics Inc | Atkins B. Michael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |